OR2J2 Antibody

What is OR2J2 and why is it significant for research?

OR2J2 (Olfactory Receptor Family 2 Subfamily J Member 2) is a G-protein coupled receptor within the olfactory receptor family. The canonical human protein consists of 312 amino acid residues with a molecular weight of approximately 35.2 kDa and primarily localizes to the cell membrane . OR2J2 has several synonyms in research literature, including OR6-8, OR6.3.8, ORL684, dJ80I19.4, and hs6M1-6 . The significance of OR2J2 stems from its role in olfactory signaling pathways and potential involvement in non-olfactory tissues, making it an important target for researchers studying sensory perception and related disorders.

What types of OR2J2 antibodies are currently available for research?

Current research tools for OR2J2 detection include polyclonal antibodies such as rabbit-derived anti-OR2J2 antibodies designed for Western blot applications . Additionally, detection systems like ELISA kits for various species including mouse, rat, sheep, goat, and pig models are available . The antibody selection should align with specific experimental requirements, including:

What are the recommended storage conditions for OR2J2 antibodies?

Proper storage is critical for maintaining antibody functionality. For polyclonal OR2J2 antibodies, long-term storage at -20°C for up to one year is recommended . For frequent use scenarios, short-term storage at 4°C for up to one month is acceptable . Importantly, repeated freeze-thaw cycles should be avoided as they can degrade antibody quality and reduce binding efficiency . When working with ELISA kits, component-specific storage recommendations should be followed to maintain detection sensitivity and specificity.

What are the optimal parameters for Western blot detection of OR2J2?

Western blot detection of OR2J2 requires careful optimization of several parameters. Based on validated protocols, the recommended dilution range for anti-OR2J2 antibodies is 1:500-1:2000 . When preparing samples, researchers should consider that OR2J2 has a calculated molecular weight of 35,204 Da . The antibody composition typically includes PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide . Successful detection depends on optimization of:

• Sample preparation and protein loading amounts

• Transfer conditions and membrane selection

• Blocking solution composition and incubation time

• Primary antibody dilution and incubation parameters

• Secondary antibody selection based on detection system

How should OR2J2 ELISA assays be designed and performed?

When quantifying OR2J2 levels using ELISA, researchers should establish standard curves using the provided standards (typically ranging from 50-1000 pg/mL) . The competition ELISA method often used for OR2J2 requires careful attention to sample preparation and technical execution. The analytical workflow involves:

• Sample preparation from appropriate sources (cell culture supernatant, plasma, serum, or tissue homogenate)

• Standard curve generation using provided calibrators

• Enzyme conjugate addition and incubation

• Thorough washing to remove unbound material

• Substrate addition and color development

• Absorbance measurement at 450 nm

• Concentration determination using standard curve interpolation

Equipment requirements include precision pipettes, microplate readers capable of 450 nm measurements, incubators (37°C), and centrifuges (3000 × g) .

How can cross-reactivity with related olfactory receptors be assessed and mitigated?

Cross-reactivity represents a significant challenge in olfactory receptor research due to sequence homology. While OR2J2 antibodies are designed to be specific, validation should include:

• Positive controls using recombinant OR2J2 protein or overexpression systems

• Negative controls using tissues/cells known not to express OR2J2

• Peptide competition assays using the immunizing peptide (for polyclonal antibodies raised against the amino acid region 263-312)

• Comparison with alternative detection methods such as RT-PCR or RNA-seq

• Western blot analysis to confirm band specificity at the expected molecular weight

Cross-reactivity with non-human tissues should be experimentally validated, as suggested by researcher inquiries about monkey tissue compatibility .

What tissue expression patterns have been observed for OR2J2?

Understanding OR2J2 tissue distribution is essential for experimental design. The Human Protein Atlas provides comprehensive expression data across multiple tissue types . While complete distribution data is not fully available in the search results, researchers have reported:

• Expression in testis tissue (evidenced by researcher inquiries about testis sample analysis)

• Potential expression in other tissues as suggested by the Human Protein Atlas database

When designing experiments targeting specific tissues, verification of OR2J2 expression in the target tissue is advisable through preliminary RT-PCR or Western blot analysis.

How should inconsistent Western blot results with OR2J2 antibodies be addressed?

Researchers working with OR2J2 antibodies have reported variable results, particularly with testis samples . Troubleshooting strategies include:

• Sample preparation optimization: Ensure complete protein denaturation and consider specialized extraction buffers for membrane proteins

• Blocking optimization: Test alternative blocking agents (5% milk, 5% BSA) to reduce background

• Antibody concentration adjustment: Titrate primary antibody concentrations

• Incubation conditions modification: Extend primary antibody incubation time (overnight at 4°C)

• Detection system evaluation: Compare chemiluminescent versus fluorescent detection methods

When analyzing Western blot data, confirm that the observed band corresponds to the expected molecular weight (35.2 kDa for human OR2J2) .

What controls are essential for validating OR2J2 antibody specificity?

Rigorous validation requires comprehensive controls:

• Positive tissue controls with documented OR2J2 expression

• Negative controls using tissues with no OR2J2 expression

• Peptide blocking controls using the immunizing peptide

• Recombinant OR2J2 protein standards

• siRNA or CRISPR knockout validation to confirm antibody specificity

The immunogen used for antibody production (synthetic peptide from human OR2J2, amino acids 263-312) provides the basis for peptide blocking experiments .

How are OR2J2 post-translational modifications characterized using available antibodies?

OR2J2 undergoes post-translational modifications, notably glycosylation . Characterizing these modifications requires specialized approaches:

• Deglycosylation assays using enzymes like PNGase F followed by Western blot analysis

• Mobility shift analysis comparing treated and untreated samples

• Mass spectrometry validation of specific modification sites

• Comparative analysis across tissue types to identify tissue-specific modification patterns

When analyzing glycosylation, researchers should anticipate potential shifts in apparent molecular weight from the calculated 35.2 kDa.

What techniques are recommended for studying OR2J2 at the cellular and subcellular levels?

Investigating OR2J2's subcellular localization and trafficking requires specialized methods:

• Immunocytochemistry and immunofluorescence techniques

• Subcellular fractionation followed by Western blot analysis

• Co-immunoprecipitation to identify interaction partners

• Live-cell imaging using OR2J2 fusion proteins

• Electron microscopy for ultrastructural localization

As a G-protein coupled receptor, OR2J2 is expected to primarily localize to the plasma membrane , though trafficking dynamics may involve endoplasmic reticulum and Golgi compartments during processing.